Related Experiment Video

Updated: Sep 27, 2026

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

Conversion of drug-induced differentiation to apoptosis by pharmacologic cyclin-dependent kinase inhibitors

Steven Grant1, Paul Dent

  • 1Department of Medicine, Virginia Commonwealth University, Medical College of Virginia, Richmond, USA. stgrant@hsc.vcu.edu

Cell Cycle (Georgetown, Tex.)
|January 28, 2003
PubMed

Insights

Cyclin-dependent kinase (CDK) inhibitors unexpectedly antagonize cancer cell differentiation, causing apoptosis. This finding challenges previous assumptions and may guide new cancer treatment strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Novel anticancer agents target cell differentiation (e.g., protein kinase C activators, histone deacetylase inhibitors) or inhibit cyclin-dependent kinases (CDKs).
  • Cell cycle arrest, a prerequisite for differentiation, suggests CDK inhibitors could enhance maturation responses.

Purpose of the Study:

  • To investigate the interaction between CDK inhibitors and differentiation-inducing agents in human leukemia cells.
  • To elucidate the molecular mechanisms underlying the effects of CDK inhibitors on cancer cell maturation.

Main Methods:

  • Pharmacologic inhibition of cyclin-dependent kinases (CDKs) in human leukemia cell models.
  • Analysis of cell cycle regulation, differentiation markers, and apoptotic pathways.
  • Assessment of mitochondrial injury and regulatory protein expression.

Main Results:

  • Contrary to expectations, CDK inhibitors did not promote differentiation in human leukemia cells.
  • CDK inhibitors antagonized the maturation process induced by differentiation agents.
  • Dysregulation of cell cycle and apoptotic proteins led to mitochondrial injury and apoptosis.

Conclusions:

  • Pharmacologic CDK inhibitors can unexpectedly inhibit cancer cell differentiation and induce apoptosis.
  • Understanding these interactions is crucial for developing novel chemotherapeutic strategies.
  • Findings may inform future treatments for hematopoietic and non-hematopoietic malignancies.

More Related Videos

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.